TD Cowen Downgrades Jasper Therapeutics (JSPR) to Hold, 'now at a critical juncture'
Tweet Send to a Friend
(Updated - May 15, 2026 5:30 AM EDT)
TD Cowen analyst Yaron Werber downgraded Jasper Therapeutics (NASDAQ: JSPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TD Cowen analyst Yaron Werber downgraded Jasper Therapeutics (NASDAQ: JSPR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
